Insider Buying: Retractable Technologies, Inc. (NYSEAMERICAN:RVP) Major Shareholder Buys 18,597 Shares of Stock

Retractable Technologies, Inc. (NYSEAMERICAN:RVPGet Rating) major shareholder Braden Michael Leonard purchased 18,597 shares of the stock in a transaction on Monday, May 23rd. The stock was bought at an average price of $3.97 per share, for a total transaction of $73,830.09. Following the completion of the transaction, the insider now directly owns 3,721,998 shares of the company’s stock, valued at $14,776,332.06. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Braden Michael Leonard also recently made the following trade(s):

  • On Wednesday, May 25th, Braden Michael Leonard acquired 44,877 shares of Retractable Technologies stock. The stock was acquired at an average cost of $3.99 per share, for a total transaction of $179,059.23.
  • On Thursday, May 19th, Braden Michael Leonard acquired 24,144 shares of Retractable Technologies stock. The stock was acquired at an average cost of $3.92 per share, for a total transaction of $94,644.48.
  • On Tuesday, May 17th, Braden Michael Leonard acquired 40,984 shares of Retractable Technologies stock. The stock was acquired at an average cost of $3.85 per share, for a total transaction of $157,788.40.
  • On Wednesday, May 11th, Braden Michael Leonard acquired 30,000 shares of Retractable Technologies stock. The stock was acquired at an average cost of $3.80 per share, for a total transaction of $114,000.00.
  • On Monday, May 9th, Braden Michael Leonard acquired 22,663 shares of Retractable Technologies stock. The stock was acquired at an average cost of $3.74 per share, for a total transaction of $84,759.62.
  • On Monday, May 2nd, Braden Michael Leonard purchased 153,428 shares of Retractable Technologies stock. The shares were purchased at an average cost of $3.84 per share, for a total transaction of $589,163.52.
  • On Thursday, April 28th, Braden Michael Leonard purchased 156,070 shares of Retractable Technologies stock. The shares were purchased at an average cost of $3.58 per share, for a total transaction of $558,730.60.

Shares of RVP traded up $0.11 during trading hours on Wednesday, hitting $4.00. 136,920 shares of the stock traded hands, compared to its average volume of 163,695. The company has a quick ratio of 1.92, a current ratio of 2.44 and a debt-to-equity ratio of 0.02. Retractable Technologies, Inc. has a 1-year low of $3.28 and a 1-year high of $13.91. The firm has a market capitalization of $131.74 million, a PE ratio of 2.92 and a beta of 1.89.

Retractable Technologies (NYSEAMERICAN:RVPGet Rating) last issued its quarterly earnings results on Thursday, March 31st. The company reported $0.61 earnings per share (EPS) for the quarter. Retractable Technologies had a return on equity of 68.86% and a net margin of 28.99%. The business had revenue of $59.46 million for the quarter.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in RVP. Vanguard Group Inc. increased its holdings in Retractable Technologies by 12.6% in the first quarter. Vanguard Group Inc. now owns 1,092,079 shares of the company’s stock valued at $5,188,000 after purchasing an additional 122,231 shares during the last quarter. Renaissance Technologies LLC bought a new stake in Retractable Technologies in the fourth quarter valued at about $680,000. Allspring Global Investments Holdings LLC bought a new stake in Retractable Technologies in the fourth quarter valued at about $530,000. Marshall Wace LLP increased its holdings in Retractable Technologies by 30.4% in the third quarter. Marshall Wace LLP now owns 219,504 shares of the company’s stock valued at $2,421,000 after purchasing an additional 51,134 shares during the last quarter. Finally, Morgan Stanley increased its holdings in Retractable Technologies by 239.8% in the second quarter. Morgan Stanley now owns 62,655 shares of the company’s stock valued at $724,000 after purchasing an additional 44,217 shares during the last quarter. Institutional investors and hedge funds own 24.02% of the company’s stock.

Retractable Technologies Company Profile (Get Rating)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Featured Articles

Insider Buying and Selling by Quarter for Retractable Technologies (NYSEAMERICAN:RVP)

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.